Trial Profile
Efficacy and Tolerability of Multiple-Dose Bortezomib Desensitization in sensitized kidney transplant (KTx) candidates
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 04 Dec 2015 New trial record